NDC11 00591040401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00591-0404-01 | 00591-0404 |
| 00591-0404-1 | 00591-0404 |
| 00591-404-01 | 00591-404 |
| 0591-0404-01 | 0591-0404 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Actavis Pharma, Inc. | a0343397-897b-46d6-943f-a87e07e1de10 | 2024-01-30 | Warnings, Adverse reactions | 0591-0404-01 0591-0404 00591040401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.